The House passed an omnibus spending bill Thursday that boosts FDA funding by $135 million for fiscal 2018 for a total of $2.9 billion in discretionary spending.

The agency’s total funding including revenue from user fees will be $5.15 billion, according to the House Appropriations Committee.

The omnibus bill increases funding for medical product safety activities by $113.2 million, including $15 million to fund the new Oncology Center of Excellence. The increase includes a one-time payment of $94 million to expand FDA’s efforts at international mail facilities to address the opioid crisis.